Transcobalamin II Deficiency Can Present without Hematological Manifestations: A Novel TCN2 Gene Variant
Asian Hematology Research Journal,
Transcobalamin II (TC) deficiency is a rare but serious metabolic disorder. It usually presents in the first year of life with failure to thrive, megaloblastic anemia and pancytopenia. Other features includes hypotonia, ataxia, lethargy, vomiting, diarrhea, mucosal ulceration, recurrent infections, agammaglobulinemia, methylmalonic aciduria and in rare cases, seizures. Besides, clinical presentation of TC deficiency may not be obvious thus leading to complex issues around diagnosis and treatment. Herein, we present TC II deficiency diagnosed in a 14 months old boy who presented with progressive myoclonic seizure, ataxia, truncal hypotonia, without any hematological manifestations and found to have a novel variant in the TCN2 gene.
- Transcobalamin II deficiency
- TCN2 gene
- megaloblastic anemia
- neurological deficits
How to Cite
Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. BMJ. 2014;349: 5226.
Hakami N, Neiman PE, Canellos GP, Lazerson J. Neonatal megaloblastic anemia due to inherited transcobalamin II deficiency in two siblings. N Engl J Med 1971;285:1163–70.
Nawaz A, Khattak NN, Khan MS, Nangyal H, Sabri S, Shakir M. Deficiency of vitamin B12 and its relation with neurological disorders: A critical review. J. Basic Appl. Zool. 2020;81:1–9.
Trakadis YJ, Alfares A, Bodamer OA, et al. Update on transcobalamin deficiency: clinical presentation, treatment and outcome. J Inherit Metab Dis. 2014;37: 461–73.
Kose E, Besci O, Gudeloglu E, et al. Transcobalamin II deficiency in twins with a novel variant in the TCN2 gene: case report and review of literature. J Pediatr Endocrinol Metab. 2020;33(11):1487-1499.
Alam MM (editor). In book, A Practical Guide I Pediatric Hematology. Lulu Press, Morrisville (USA). 2021; p3-7.
Arlet JB, Varet B, Besson C. Favorable long-term outcome of a patient with transcobalamin II deficiency. Ann Intern Med. 2002;137:704–5.
Schiff M, Ogier de Baulny H, Bard G, Barlogis V, Hamel C, Moat SJ, et al. Should transcobalamin deficiency be treated aggressively?. J Inherit Metab Dis. 2010;33:223–9.
Yildirim ZK, Nexo E, Rupar T, Büyükavci M. Seven patients with transcobalamin deficiency diagnosed between 2010 and 2014: a single-center experience. J Pediatr Hematol Oncol. 2017;39:38–41.
Prasad C, Rosenblatt DS, Corley K, Cairney AE, Rupar CA. Transcobalamin (TC) deficiency–potential cause of bone marrow failure in childhood. J Inherit Metab Dis. 2008;31:S287–92.
Ammouri W, Harmouche H, Khibri H, Benkirane S, Azlarab M, et al. Neurological Manifestations of Cobalamin Deficiency. Open Access J Neurol Neurosurg. 2019; 12(2): 555834.
Maamar M, Tazi-Mezalek Z, Harmouche H, et al. Neurological manifestations of vitamin B12 deficiency: a retrospective study of 26 cases. Rev Med Interne. 2006;27(6):442-7.
Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988; 318(26): 1720-1728.
Serin HM, Arslan EA. Neurological symptoms of vitamin B12 deficiency: analysis of pediatric patients. Acta Clin Croat. 2019;58(2):295-302.
Bibi H, Gelman-Kohan Z, Baumgartner ER, Rosenblatt DS. Transcobalamin II deficiency with methylmalonic aciduria in three sisters. J Inherit Metab Dis. 1999; 22:765–72.
Herrmann W, Obeid R. Cobalamin deficiency. Subcell Biochem. 2012;56:301–22.
Ünal S, Karahan F, Arıkoğlu T, Akar A, Kuyucu S. Different presentations of patients withtranscobalamin II deficiency: a singlecenter experience from Turkey. Turk J Haematol. 2019;36:37–42.
Nashabat M, Maegawa G, Nissen PH, et al. Long-term outcome of 4 patients with transcobalamin deficiency caused by 2 novel TCN2 mutations. J Pediatr Hematol Oncol. 2017;39:e430–6.
Abstract View: 173 times
PDF Download: 9 times